The Food and Drug Administration is currently reporting shortages of dextrose in 5%, 10%, 25% and 50% solutions. Manufacturing capacity to support these dextrose products is not expected to improve ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% ...

This titrate-up and taper-down controversy stems from concerns regarding the potential for hyperglycemia upon initiation of total parenteral nutrition (TPN) and for hypoglycemia upon discontinuation.

April 12, 2005 — The U.S. Food and Drug Administration (FDA) and PharMEDium Services have alerted healthcare professionals via letter of a nationwide recall of all 50 mL admixtures of magnesium ...

Background: In comparision with children and adults pain in the newborn infants is under assessed and under managed. Recently oral sweet solutions such as sucrose has been used for painful procedures ...